CRYOPORT, INC. Debt Instrument, Convertible, Conversion Price
CRYOPORT, INC. (CYRX) had Debt Instrument, Convertible, Conversion Price of $117.59 per share as of 2024-12-31, per its 10-K filed 2025-03-07.
Financial Statements › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentConvertibleConversionPrice1 · last filed 2025-03-07
- 2024-12-31: Debt Instrument, Convertible, Conversion Price $117.59.
- 2023-12-31: Debt Instrument, Convertible, Conversion Price $117.59.
- 2022-12-31: Debt Instrument, Convertible, Conversion Price $117.59.
- 2022-06-30: Debt Instrument, Convertible, Conversion Price $117.59.
| Period end | Debt Instrument, Convertible, Conversion Price |
|---|---|
| 2024-12-31 | $117.59 10-K · filed 2025-03-07 |
| 2023-12-31 | $117.59 10-K · filed 2024-03-13 |
| 2022-12-31 | $117.59 10-K · filed 2023-02-28 |
| 2022-06-30 | $117.59 10-Q · filed 2022-08-04 |
| 2022-03-31 | $117.59 10-Q · filed 2022-05-05 |
| 2021-12-31 | $117.59 10-K · filed 2022-02-28 |
| 2021-09-30 | $23.91 10-Q · filed 2021-11-04 |
| 2021-06-30 | $23.91 10-Q · filed 2021-08-06 |
| 2021-03-31 | $23.91 10-Q · filed 2021-05-06 |
| 2020-12-31 | $23.91 10-K · filed 2021-03-01 |
| 2020-09-30 | $23.91 10-Q · filed 2020-11-06 |
| 2020-06-30 | $23.91 10-Q · filed 2020-08-10 |
| 2014-12-31 | $10.80 10-Q · filed 2015-02-05 |
| 2014-03-31 | $10.80 10-Q · filed 2014-11-12 |
| 2013-12-31 | $0.20 10-Q · filed 2014-02-13 |
| 2013-10-31 | $0.20 10-Q · filed 2014-02-13 |
| 2013-09-30 | $0.20 10-Q · filed 2013-11-18 |
| 2013-03-31 | $3.00 10-K · filed 2013-06-25 |
| 2012-12-31 | $3.00 10-Q · filed 2013-02-14 |
| 2012-09-30 | $3.00 10-Q · filed 2012-11-09 |
| 2012-06-30 | $3.00 10-Q · filed 2012-08-14 |
| 2012-03-31 | $0.69 10-K · filed 2013-06-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |